Carriers of haplotype 2 in the CHEK2 gene seemed to have a decreased risk of death from breast cancer (P = 0.038) compared with haplotype 1 carriers, whereas carriers of the rare ERBB2 haplotypes seemed to have an increased risk of death from breast cancer (P = 0.009). This evidence concerns the gene ERBB2 and breast cancer.